Status:
NOT_YET_RECRUITING
Magnesium Sulfate Versus Lidocaine as Additives to Dexmedetomidine for Cough Suppression After Functional Endoscopic Sinus Surgery
Lead Sponsor:
Assiut University
Conditions:
Cough Suppression
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
Functional Endoscopic Sinus Surgery (FESS) is a widely performed procedure for the management of chronic rhinosinusitis and nasal polyposis. Despite being minimally invasive(1).Postoperative coughing,...
Eligibility Criteria
Inclusion
- a. Age \>18 \< 60 years old b. Both genders. c. Patients who were in risk-scoring groups I-II of the American Society of Anesthesiologists (ASA)
Exclusion
- . Active airway infection
- History of tracheal and laryngeal surgery.
- Airway tumors,
- Body mass index more than 35.
- Increased intracranial and intraocular pressure.
- Uncontrolled pulmonary diseases (bronchial asthma, chronic obstructive pulmonary disease (COPD), restrictive lung diseases).
- Patients with a known allergy or sensitivity to any study drugs.
- Patients' refusal to enroll in the study.
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT07213037
Start Date
November 1 2025
End Date
December 1 2026
Last Update
October 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.